Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
67 studies found for:    Open Studies | "Skin Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Skin Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Skin Cancer in Swiss Transplant Cohort Study
Condition: Skin Cancer
Intervention:
2 Recruiting Optical Frequency Domain Imaging for Non-melanoma Skin Cancers
Condition: Non-Melanoma Skin Cancer (NMSC)
Intervention: Device: OFDI
3 Recruiting Topical Chemoprevention of Skin Cancer Biomarkers
Condition: Non-melanoma Skin Cancer
Interventions: Drug: topical DFMO+diclofenac twice daily;   Drug: placebo
4 Recruiting Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients
Condition: Nonmelanoma Skin Cancers
Intervention: Other: have Levulan Kerastick (aminolevulinic acid) solution
5 Recruiting In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
Condition: Skin Cancer
Intervention:
6 Recruiting Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions
Condition: Skin Neoplasms
Interventions: Device: Application of AC5 Hemostatic agent;   Device: Standard application of water resistant dressing
7 Not yet recruiting A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
Conditions: Keratosis, Actinic;   Keratosis;   Skin Neoplasms
Interventions: Drug: Heliocare with Fernblock PLE technology;   Other: Sugar Pill
8 Recruiting Engaging Moms on Teen Indoor Tanning Through Social Media
Condition: Skin Cancer
Interventions: Behavioral: Health Chat including Indoor Tanning;   Behavioral: Health Chat excluding Indoor Tanning
9 Recruiting Skin Cancer Screening Education Study
Conditions: Skin Tumors;   Melanoma;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention: Other: Skin Cancer Screening Training
10 Recruiting Post Excision/Mohs Scar Laser Resurfacing
Condition: Skin Cancer
Intervention: Device: Laser Treatment
11 Recruiting Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin
Condition: Skin Cancer
Intervention:
12 Not yet recruiting 5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
Conditions: Ectropion;   Skin Neoplasms
Interventions: Drug: 5-Fluorouracil;   Other: Normal saline
13 Recruiting HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
Conditions: Melanoma;   Skin Neoplasms
Intervention: Drug: Vorinostat
14 Recruiting Dietary Prevention of Photodamage in Skin With Grapes
Condition: Non-melanoma Skin Cancer
Intervention: Other: Reconstituted grape powder
15 Recruiting Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Conditions: Recurrent Skin Cancer;   Squamous Cell Carcinoma of the Skin
Interventions: Biological: cetuximab;   Other: laboratory biomarker analysis
16 Recruiting A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
Conditions: Carcinoma, Basal Cell,;   Skin Neoplasm
Intervention: Biological: ASN-002
17 Not yet recruiting Early Detection of Skin Cancer With Sensor Technology
Condition: Carcinoma, Basal Cell
Intervention: Device: WR-22 model microwave sensor
18 Recruiting XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
Conditions: Melanoma;   Skin Cancer
Interventions: Drug: XL888;   Drug: Vemurafenib;   Drug: Cobimetinib
19 Recruiting Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
Conditions: Melanoma (Skin);   Skin Cancer
Interventions: Drug: Nivolumab;   Procedure: Surgery to Remove Tumor for Growth of TIL;   Drug: CD137;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: TIL Infusion;   Drug: Interleukin-2
20 Recruiting Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
Conditions: Melanoma;   Skin Cancer
Interventions: Drug: Panobinostat;   Drug: Ipilimumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.